Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST)
Publication
, Conference
O'Connor, C; Anand, I; Fiuzat, M; Plehn, J; Goulieb, S; Silver, M; Lindenfeld, J; Miller, A; White, M; Robertson, A; Bristow, M; Carson, P
Published in: JOURNAL OF CARDIAC FAILURE
August 1, 2008
Duke Scholars
Published In
JOURNAL OF CARDIAC FAILURE
ISSN
1071-9164
Publication Date
August 1, 2008
Volume
14
Issue
6
Start / End Page
S69 / S69
Location
Toronto, CANADA
Publisher
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
Conference Name
12th Annual Scientific Meeting of the Heart-Failure-Society-of-America
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, C., Anand, I., Fiuzat, M., Plehn, J., Goulieb, S., Silver, M., … Carson, P. (2008). Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST). In JOURNAL OF CARDIAC FAILURE (Vol. 14, pp. S69–S69). Toronto, CANADA: CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.
O’Connor, C., I. Anand, M. Fiuzat, J. Plehn, S. Goulieb, M. Silver, J. Lindenfeld, et al. “Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST).” In JOURNAL OF CARDIAC FAILURE, 14:S69–S69. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2008.
O’Connor C, Anand I, Fiuzat M, Plehn J, Goulieb S, Silver M, et al. Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST). In: JOURNAL OF CARDIAC FAILURE. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS; 2008. p. S69–S69.
O’Connor, C., et al. “Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST).” JOURNAL OF CARDIAC FAILURE, vol. 14, no. 6, CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2008, pp. S69–S69.
O’Connor C, Anand I, Fiuzat M, Plehn J, Goulieb S, Silver M, Lindenfeld J, Miller A, White M, Robertson A, Bristow M, Carson P. Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST). JOURNAL OF CARDIAC FAILURE. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS; 2008. p. S69–S69.
Published In
JOURNAL OF CARDIAC FAILURE
ISSN
1071-9164
Publication Date
August 1, 2008
Volume
14
Issue
6
Start / End Page
S69 / S69
Location
Toronto, CANADA
Publisher
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
Conference Name
12th Annual Scientific Meeting of the Heart-Failure-Society-of-America
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology